Foscarnet in the Treatment of Cytomegalovirus Retinitis in Acquired Immune Deficiency Syndrome
- 1 June 1989
- journal article
- research article
- Published by Elsevier in Ophthalmology
- Vol. 96 (6) , 865-874
- https://doi.org/10.1016/s0161-6420(89)32824-7
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- DECLINING LEVELS OF HIV P24 ANTIGEN IN SERUM DURING TREATMENT WITH FOSCARNETThe Lancet, 1988
- Treatment of Cytomegalovirus Retinitis with Trisodium Phosphonoformate Hexahydrate (Foscarnet)The Journal of Infectious Diseases, 1988
- Treatment of Serious Cytomegalovirus Infections with 9-(1,3-Dihydroxy-2-Propoxymethyl)Guanine in Patients with AIDS and Other ImmunodeficienciesNew England Journal of Medicine, 1986
- Pharmacokinetics, safety and preliminary clinical experiences using foscarnet in the treatment of cytomegalovirus infections in bone marrow and renal transplant recipientsJournal of Antimicrobial Chemotherapy, 1986
- Acquired Immunodeficiency Syndrome (AIDS): The Disease and Its Ocular ManifestationsInternational Ophthalmology Clinics, 1986
- INHIBITION OF HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE III IN VITRO BY PHOSPHONOFORMATEThe Lancet, 1985
- FOSCARNET FOR CYTOMEGALOVIRUS PNEUMONITISThe Lancet, 1985
- Ocular Manifestations of the Acquired Immune Deficiency SyndromeInternational Ophthalmology Clinics, 1985
- Cytomegalovirus retinitis: a manifestation of the acquired immune deficiency syndrome (AIDS).British Journal of Ophthalmology, 1983
- Reversible Inhibition of Cytomegalovirus Replication by PhosphonoformateIntervirology, 1980